Filing Details

Accession Number:
0001628280-21-014732
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-28 16:33:52
Reporting Period:
2021-07-26
Accepted Time:
2021-07-28 16:33:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1672688 Absci Corp ABSI () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534260 Casdin Partners Gp, Llc 1350 Avenue Of The Americas, Suite 2600
New York NY 10019
Yes No No No
1534261 Casdin Capital, Llc 1350 Avenue Of The Americas, Suite 2600
New York NY 10019
Yes No No No
1534265 Casdin Partners Master Fund, L.p. 1350 Avenue Of The Americas, Suite 2600
New York NY 10019
Yes No No No
1823061 Casdin Private Growth Equity Fund, L.p. 1350 Avenue Of The Americas, Suite 2600
New York NY 10019
Yes No No No
1864554 Casdin Private Growth Equity Fund Gp, Llc 1350 Avenue Of The Americas, Suite 2600
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-26 4,209,573 $0.00 4,209,573 No 4 C Direct
Common Stock Acquisiton 2021-07-26 973,260 $0.00 5,182,833 No 4 C Direct
Common Stock Acquisiton 2021-07-26 1,562,500 $16.00 6,745,333 No 4 P Direct
Common Stock Acquisiton 2021-07-26 973,260 $0.00 973,260 No 4 C Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
No 4 C Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series E Preferred Stock Disposition 2021-07-26 1,274,431 $0.00 4,209,573 $0.00
Common Stock Convertible Note Disposition 2021-07-26 0 $0.00 973,260 $13.12
Common Stock Convertible Note Disposition 2021-07-26 0 $0.00 973,260 $13.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. These shares of the Series E Preferred Stock automatically converted on a one-for-3.3031 basis into the number of shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), shown in Column 7 immediately upon closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series E Preferred Stock had no expiration date.
  2. These shares are held by Casdin Partners Master Fund, L.P. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Partners Master Fund, L.P., and Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Partners Master Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Partners GP. Each of Casdin Capital, Casdin Partners GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports
  3. This convertible promissory note ("Convertible Note") had a maturity date of September 16, 2023. The principal and accrued interest under the Convertible Note converted upon the closing of the IPO into shares of Common Stock at a conversion price equal to $13.12 per share without payment of additional consideration.
  4. These shares are held by Casdin Private Growth Equity Fund, L.P. Casdin Capital is the investment adviser to Casdin Private Growth Equity Fund, L.P. and Casdin Private Growth Equity Fund GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Equity Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Private Growth GP. Each of Casdin Capital, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports.